{
  "success": true,
  "pagesUsed": [
    1,
    2,
    3,
    6,
    7,
    8,
    9,
    10,
    14,
    15,
    16,
    17,
    18,
    19,
    25,
    26,
    27,
    28,
    29,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Pembrolizumab (MK-3475)",
        "type": {
          "id": "1e2d8508-a3f8-4549-b790-52e8115ca656",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "01194a01-7516-411e-a7f8-2b2365897997",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-1 monoclonal antibody for advanced/metastatic esophageal cancer",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Paclitaxel",
        "type": {
          "id": "42e39c65-5b83-4660-af9a-a9fb55731ad4",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "dab4525f-2863-46b1-8de1-0c8b62891ad7",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Docetaxel",
        "type": {
          "id": "9a386da3-87ea-4240-a680-8e777236f845",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "22619cf5-5252-4df1-b776-5f226a8819e2",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Irinotecan",
        "type": {
          "id": "024fda46-38db-43af-a42a-69e85645be21",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "c77d043f-fc6e-4cfe-b3f4-09639db1aa0a",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "7684cd98-76a6-4ac7-9c89-c3ca1c472f9f",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9815de24-d725-4e6a-a6e0-132e9f4bfa3c",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of immune-related adverse events and as premedication for chemotherapy"
      },
      {
        "id": "int_6",
        "name": "Antihistamines",
        "type": {
          "id": "ac760a37-7dcf-4c9c-8bf6-820ce41d4a48",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "75677485-fddd-4adb-a7a9-77bd70284f91",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for infusion reaction management and chemotherapy premedication"
      },
      {
        "id": "int_7",
        "name": "Antineoplastic systemic chemotherapy",
        "type": {
          "id": "51cbdb8c-9a40-48a1-9f63-d7765061d002",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "cbb4e3d2-623a-4fde-8512-18f95cb0cfc0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited during screening and treatment phase unless specified in protocol"
      },
      {
        "id": "int_8",
        "name": "Live vaccines",
        "type": {
          "id": "96938f6a-f273-47c3-a5e1-d7f81d01e0fe",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b18fcca1-d1bc-4ab3-aad6-3445b5c39e98",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 30 days prior to first dose and during trial for pembrolizumab arm"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Pembrolizumab",
        "administrableDoseForm": {
          "id": "912dc09e-226e-4c25-a760-b5922e9e01da",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "758d7a20-b622-4bb5-88a5-7b453ba50c79",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "dd0cea90-c766-420c-a650-8d65bec99609",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Merck Sharp & Dohme Corp."
      },
      {
        "id": "prod_2",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "ca3431bc-a31a-46ba-940d-2288e16a0a06",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "d7e2c2fd-329a-42aa-bb5d-17d845dfac87",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "2beabc53-f5f8-47ed-80aa-b3b735ed4f5e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Docetaxel",
        "administrableDoseForm": {
          "id": "a0c0baa0-527f-4002-ae19-29c07d2e7b75",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "4c931a65-30a7-4c46-b732-eda7c3f6e0fc",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "1458d903-641b-4d03-bbf5-08cc0ecaf500",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Irinotecan",
        "administrableDoseForm": {
          "id": "77a31228-5f5a-491c-a2a3-fe6c97d8e0f6",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "1b7e159a-d4c8-46b8-9459-e08ed43de5cc",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "e518c622-b474-451c-8839-4fb4fa1d6a74",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Pembrolizumab Regimen",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "Every 3 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression, unacceptable toxicity, or 35 administrations (approx. 2 years)"
      },
      {
        "id": "admin_2",
        "name": "Paclitaxel Regimen",
        "instanceType": "Administration",
        "dose": "80-100 mg/m2",
        "doseFrequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_3",
        "name": "Docetaxel Regimen",
        "instanceType": "Administration",
        "dose": "75 mg/m2",
        "doseFrequency": "Day 1 of every 21-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_4",
        "name": "Irinotecan Regimen",
        "instanceType": "Administration",
        "dose": "180 mg/m2",
        "doseFrequency": "Day 1 of every 14-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Pembrolizumab",
        "instanceType": "Substance",
        "description": "Humanized monoclonal antibody against PD-1"
      },
      {
        "id": "sub_2",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Taxane antineoplastic agent"
      },
      {
        "id": "sub_3",
        "name": "Docetaxel",
        "instanceType": "Substance",
        "description": "Taxane antineoplastic agent"
      },
      {
        "id": "sub_4",
        "name": "Irinotecan",
        "instanceType": "Substance",
        "description": "Topoisomerase I inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 8,
      "productCount": 4,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Pembrolizumab (MK-3475)",
        "role": "Investigational Product",
        "description": "Anti-PD-1 monoclonal antibody for advanced/metastatic esophageal cancer"
      },
      {
        "name": "Paclitaxel",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Docetaxel",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Irinotecan",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Corticosteroids",
        "role": "Rescue Medication",
        "description": "Used for management of immune-related adverse events and as premedication for chemotherapy"
      },
      {
        "name": "Antihistamines",
        "role": "Concomitant Medication",
        "description": "Permitted for infusion reaction management and chemotherapy premedication"
      },
      {
        "name": "Antineoplastic systemic chemotherapy",
        "role": "Concomitant Medication",
        "description": "Prohibited during screening and treatment phase unless specified in protocol"
      },
      {
        "name": "Live vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited within 30 days prior to first dose and during trial for pembrolizumab arm"
      }
    ],
    "products": [
      {
        "name": "Pembrolizumab",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Merck Sharp & Dohme Corp."
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      },
      {
        "name": "Docetaxel",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      },
      {
        "name": "Irinotecan",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Pembrolizumab",
        "description": "Humanized monoclonal antibody against PD-1"
      },
      {
        "name": "Paclitaxel",
        "description": "Taxane antineoplastic agent"
      },
      {
        "name": "Docetaxel",
        "description": "Taxane antineoplastic agent"
      },
      {
        "name": "Irinotecan",
        "description": "Topoisomerase I inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Pembrolizumab Regimen",
        "dose": "200 mg",
        "frequency": "Every 3 weeks",
        "route": "Intravenous",
        "duration": "Until disease progression, unacceptable toxicity, or 35 administrations (approx. 2 years)"
      },
      {
        "name": "Paclitaxel Regimen",
        "dose": "80-100 mg/m2",
        "frequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Docetaxel Regimen",
        "dose": "75 mg/m2",
        "frequency": "Day 1 of every 21-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Irinotecan Regimen",
        "dose": "180 mg/m2",
        "frequency": "Day 1 of every 14-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "devices": []
  }
}